Accelerating Therapies for Rare Diseases Workshop

Overview

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research and the National Institutes of Health, Office of Rare Diseases Research and National Institute of Neurological Disorders and Stroke in collaboration with the National Organization for Rare Disorders and Duke University Medical Center, offer a 3-day workshop in October 2010 in Rockville, MD on conducting research on rare diseases and orphan products. The workshop focuses on FDAs regulatory requirements and the clinical trial issues that are especially relevant to rare disease research. Please check back for updates as speaker presentations and other materials will be added as they become available prior to the workshop.

The Workshop is being held at the US Pharmacopeia Building, 12601 Twinbrook Parkway, Rockville, MD 20852.

Our Sponsors